NCT07202494View on ClinicalTrials.gov

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging

RecruitingOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

May 19, 2025

Primary Completion Date

May 18, 2030

Study Completion Date

May 18, 2030

Conditions
Multiple SclerosisNeuromyelitis Optica Spectrum DisordersMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)Alzheimer DiseaseParkinson DiseaseAmyotrophic Lateral Sclerosis (ALS)Temporal Lobe EpilepsyEpilepsyMild Traumatic Brain InjuryHealthy Aging
Interventions
OTHER

Imaging Techniques (MRI 3T & 7T, Functional, Structural, and Metabolic Imaging)

Functional MRI (fMRI) Diffusion Tensor Imaging (DTI) Sodium Imaging (23Na-MRI) Phosphorus Imaging (31P-MRI)

Trial Locations (1)

Unknown

RECRUITING

Chu Timone, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER